Rivaroxaban for the Prevention of Stroke and Systemic Embolism in People with Atrial Fibrillation (TA256)

Dabigatran Etexilate for the Prevention of Stroke and Systemic Embolism in Atrial Fibrillation (TA249)

Apixaban for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement in Adults (TA245)

Ticagrelor for the Treatment of Acute Coronary Syndromes (TA236)

Prasugrel with Percutaneous Coronary Intervention for Treating Acute Coronary Syndromes (TA317)

Rivaroxaban for the Prevention of Venous Thromboembolism after Total Hip or Knee Replacement in Adults (TA170)

VTE, Prevention of: Dabigatran (NICE)

Myocardial Infarction: Secondary prevention (NICE)

Myocardial Infarction (Acute), Use of Drugs for Early Thrombolysis (NICE)

Acute Coronary Syndromes: Glycoprotein IIb/IIIa Inhibitors (NICE)

Load More